Recordati Industria Chimica e Farmaceutica S.p.A.
RCDTF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$12.04B
Close$
$37.95
35.5% downside
Current Fair Value
35.5% downsideOvervalued by 35.5% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $12.04 Billion |
|---|---|
| Enterprise Value | - |
| Annual dividend | $1.55 |
| Dividend yield | 2.53% |
| Earnings per Share | $2.15 |
| Beta | 0.58 |
| Outstanding Shares | 203,407,000 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 21.81 |
|---|---|
| PEG | 77.8 |
| Price to Sales | 4.52 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Last Earnings Call
Report Date
July 28, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$778.37 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 10, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$761.27 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Recordati Industria Chimica e Farmaceutica S.p.A.
4,693 employees
CEO: Robert Koremans
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Af...